Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsGold Coast Health Plan Durysta Coverage | OpenPaye…
    Ask Trek AI about this page
    CurrentGold Coast Health PlanPolicy N/A

    Durysta (bimatoprost intraocular implant) Coverage

    Customize your policy alerts

    Sign up for all goldcoasthealthplan policy alerts

    Know when goldcoasthealthplan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs prior authorization and Medicare Part B coverage for Durysta, a prostaglandin analog implant used to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Providers must submit medical records documenting prior therapies and treatment response.

    Policy Summary
    PayerGold Coast Health Plan
    PolicyDurysta (bimatoprost intraocular implant) Coverage
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAug 21, 2025
    Last ReviewAug 21, 2025
    Next Review DateN/A
    Key ActionSubmit medical records documenting prior therapies and the patient's response to treatment with the prior authorization request.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    J7351Covered HCPCS code
    OAG/OHTCovered indications
    1 mcgBilling unit
    10 mcgImplant strength

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    FDA labeling
    Coverage basis

    Durysta Coverage Criteria

    Initial Durysta Coverage

    Covered when all of the following are met:

    Durysta coverage criteria

    • Covered indication

      • Open-angle glaucoma: The patient has open-angle glaucoma.
      • Ocular hypertension: The patient has ocular hypertension.
    • Treatment history documentation: Medical records document prior therapies and response to treatment.

    Initial Durysta Authorization

    Durysta is covered for the following indication when required medical information is submitted:

    Initial therapy criteria

    • Indication

      • Open-angle glaucoma: The patient has open-angle glaucoma.
      • Ocular hypertension: The patient has ocular hypertension.
    • Prior therapy response: Documentation of prior therapies and response to treatment.

    Billing Code

    Covered HCPCS CodesHCPCSCovered
    J7351Durysta (bimatoprost implant); billing unit: 1 mcg; 10 mcg implant

    Authorization and Documentation Requirements

    Prior Authorization

    Durysta Prior Authorization

    Prior authorization is required for Durysta (bimatoprost intraocular implant) billed under HCPCS J7351.

    • HCPCS J7351: Durysta (bimatoprost implant), billing unit 1 mcg; supplied as a 10 mcg implant.
    Documentation Required

    Required Medical Records

    Submit medical records supporting the request, including documentation of prior therapies and the patient's response to treatment.

    • Document prior therapies.
    • Document the patient's response to treatment.

    Durysta Overview

    Durysta (bimatoprost intraocular implant) is a prostaglandin analog used to reduce intraocular pressure. Coverage applies to patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).

    Policy Summary
    PayerGold Coast Health Plan
    PolicyDurysta (bimatoprost intraocular implant) Coverage
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAug 21, 2025
    Last ReviewAug 21, 2025
    Next Review DateN/A
    Key ActionSubmit medical records documenting prior therapies and the patient's response to treatment with the prior authorization request.
    SourceLink
    On This Page
    Durysta Coverage CriteriaBilling CodeAuthorization and Documentation RequirementsDurysta Overview
    Denial Risk

    Insufficient Documentation or Noncovered Indication

    Requests may be denied when supporting medical records are insufficient or when the requested use is not a covered indication. Durysta is covered for reduction of intraocular pressure in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).

    • Provide records documenting prior therapies and response to treatment.
    • Confirm the indication is OAG or OHT.
    • Coverage is subject to FDA-approved labeling or accepted standards of medical practice.